143 related articles for article (PubMed ID: 33377823)
1. Huntington's disease in Turkey: genetic counseling, clinical features, and outcome.
Karadag YS; Cavdarli BE; Yuksel RN
Neurol Res; 2021 May; 43(5):381-386. PubMed ID: 33377823
[No Abstract] [Full Text] [Related]
2. Clinical and genetic characteristics in patients with Huntington's disease from China.
Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations of intermediate allele carriers in Huntington disease.
Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
[TBL] [Abstract][Full Text] [Related]
4. Determinants of Onset of Huntington's Disease with Behavioral Symptoms: Insight from 92 Patients.
Lenka A; Kamble NL; Sowmya V; Jhunjhunwala K; Yadav R; Netravathi M; Kandasamy M; Moily NS; Purushottam M; Jain S; Pal PK
J Huntingtons Dis; 2015; 4(4):319-24. PubMed ID: 26682993
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
6. Preliminary analysis of Huntington's Disease in South Korea.
Shin CW; Choi YJ; Kim M; Jeon BS
J Huntingtons Dis; 2013; 2(1):83-7. PubMed ID: 25063431
[TBL] [Abstract][Full Text] [Related]
7. Exploring the correlates of intermediate CAG repeats in Huntington disease.
Ha AD; Jankovic J
Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Huntington's disease with 40-42 CAG expansion.
Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
[TBL] [Abstract][Full Text] [Related]
9. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
[TBL] [Abstract][Full Text] [Related]
10. Risk Assessment for Huntington's Disease for (Future) Offspring Requires Offering Preconceptional CAG Analysis to Both Partners.
Tibben A; Dondorp WJ; de Wert GM; de Die-Smulders CE; Losekoot M; Bijlsma EK
J Huntingtons Dis; 2019; 8(1):71-78. PubMed ID: 30689590
[TBL] [Abstract][Full Text] [Related]
11. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.
Louis ED; Anderson KE; Moskowitz C; Thorne DZ; Marder K
Arch Neurol; 2000 Sep; 57(9):1326-30. PubMed ID: 10987900
[TBL] [Abstract][Full Text] [Related]
12. Huntington's Disease in Chile: Epidemiological and Genetic Aspects.
Solís-Añez E; Salles PA; Rojas N; Benavides O; Chaná-Cuevas P
Neuroepidemiology; 2023; 57(3):176-184. PubMed ID: 37121230
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan.
Nakashima K; Watanabe Y; Kusumi M; Nanba E; Maeoka Y; Nakagawa M; Igo M; Irie H; Ishino H; Fujimoto A; Goto J; Takahashi K
Neuroepidemiology; 1996; 15(3):126-31. PubMed ID: 8700304
[TBL] [Abstract][Full Text] [Related]
14. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
[TBL] [Abstract][Full Text] [Related]
16. The genetic analysis of Turkish patients with Huntington's disease.
Ataç FB; Elibol B; Schaefer F
Acta Neurol Scand; 1999 Sep; 100(3):195-8. PubMed ID: 10478585
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic investigation of a Brazilian family with Huntington's disease.
Agostinho LA; Spitz M; Pereira JS; Paiva CL
Funct Neurol; 2016; 31(3):135-42. PubMed ID: 27678206
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics in patients with Huntington's Disease from Argentina.
Gatto E; Parisi V; Persi G; Converso DP; Etcheverry JL; Varela V; Lopez A; Alba L; Fretchel G
Parkinsonism Relat Disord; 2012 Feb; 18(2):166-9. PubMed ID: 21962718
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic data of Huntington disease in Moroccan patients.
Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]